enGene Therapeutics (ENGN)

enGene Therapeutics (ENGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ENGN last traded at $1.75, 4.17% on the day.
• enGene Therapeutics: market cap $117.28M, P/E -6.0.
• Over the past year ENGN returned -72.40%; year to date -80.62%.

Updated 2026-11-07 12:02 UTC